AU7262800A - Diagnostic and therapeutic methods in autoimmune disease - Google Patents

Diagnostic and therapeutic methods in autoimmune disease

Info

Publication number
AU7262800A
AU7262800A AU72628/00A AU7262800A AU7262800A AU 7262800 A AU7262800 A AU 7262800A AU 72628/00 A AU72628/00 A AU 72628/00A AU 7262800 A AU7262800 A AU 7262800A AU 7262800 A AU7262800 A AU 7262800A
Authority
AU
Australia
Prior art keywords
diagnostic
autoimmune disease
therapeutic methods
therapeutic
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72628/00A
Inventor
David Hoar
Paul Keown
Abbas Khani-Hanjani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2282062 external-priority patent/CA2282062A1/en
Priority claimed from CA 2303504 external-priority patent/CA2303504A1/en
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of AU7262800A publication Critical patent/AU7262800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU72628/00A 1999-09-08 2000-09-08 Diagnostic and therapeutic methods in autoimmune disease Abandoned AU7262800A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CA2282062 1999-09-08
CA 2282062 CA2282062A1 (en) 1999-09-08 1999-09-08 Diagnostic methods in autoimmune disease
US16061899P 1999-10-20 1999-10-20
US60160618 1999-10-20
CA2303504 2000-04-10
CA 2303504 CA2303504A1 (en) 1999-09-08 2000-04-10 Diagnostic methods in autoimmune disease
PCT/CA2000/001043 WO2001018240A2 (en) 1999-09-08 2000-09-08 Diagnostic and therapeutic methods in autoimmune disease

Publications (1)

Publication Number Publication Date
AU7262800A true AU7262800A (en) 2001-04-10

Family

ID=27171032

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72628/00A Abandoned AU7262800A (en) 1999-09-08 2000-09-08 Diagnostic and therapeutic methods in autoimmune disease

Country Status (4)

Country Link
EP (1) EP1212463A2 (en)
JP (1) JP2003508081A (en)
AU (1) AU7262800A (en)
WO (1) WO2001018240A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0613844D0 (en) * 2006-07-12 2006-08-23 Progenika Biopharma Sa Methods and products for in vitro genotyping
JP2010526303A (en) * 2007-05-03 2010-07-29 セントコア・オーソ・バイオテツク・インコーポレーテツド Matrix marker model and method for evaluating and treating arthritis and related diseases
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
RU2523413C1 (en) * 2012-12-14 2014-07-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Уральская государственная медицинская академия Министерства здравоохранения и социального развития Российской Федерации" (ГБОУ ВПО УГМА Минздравсоцразвития России) DIAGNOSTIC TECHNIQUE FOR RHEUMATOID ARTHRITIS IF MUTATED CITRULLINATED VIMENTIN ANTIBODIES (Anti-MCV) ARE FOUND IN ORAL FLUID

Also Published As

Publication number Publication date
WO2001018240A2 (en) 2001-03-15
JP2003508081A (en) 2003-03-04
EP1212463A2 (en) 2002-06-12
WO2001018240A3 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
AU2001275177A1 (en) Cardiac disease treatment and device
AU2001253565A1 (en) Cardiac disease treatment and device
AU2001275176A1 (en) Cardiac disease treatment and device
AU2001281369A1 (en) Cardiac disease treatment and device
AU2815900A (en) Clinical and diagnostic database
AU3884701A (en) Cardiac methods and system
AUPQ090499A0 (en) Heart assist device and system
AU5788300A (en) Medical treatment method and kit
AU2655599A (en) Endoluminal implant with therapeutic and diagnostic capability
AU3364099A (en) Diagnosis of disease state using mrna profiles in peripheral leukocytes
AU2002218026A1 (en) Cardiovascular disease diagnostic and therapeutic targets
AU5536196A (en) Cancer diagnosis and therapy based on mutations in tgf-beta receptors
AU2001286902A1 (en) Patient analysis and risk reduction system and associated methods
AU715620C (en) Therapeutic methods and uses
AU1164601A (en) Therapeutic use and formulation
AU2976597A (en) Autoimmune disease therapeutic agent
AU2087799A (en) Diagnostic and therapeutic methods based upon valpha24jalphaq t cells
AU4765800A (en) Gadolinium complex tetramides and use in medical imaging
AU7262800A (en) Diagnostic and therapeutic methods in autoimmune disease
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
IL151019A0 (en) Microcompetition and human disease
AU3628697A (en) Lipid-binding proteins and their therapeutic and diagnostic use
AU4459797A (en) Peptide as diagnostic and therapeutic agent for autoimmune diseases
AU4293600A (en) Recombinant protein uk114 and its use in therapy and diagnostics
EP1158856A4 (en) Human fas

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase